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ABSTRACT
Integrin conformational changes mediate integrin activation and signaling triggered by
intracellular molecules or extracellular ligands. Even though it has been shown that TM and/or
cytoplasmic  and  domains associate in the resting state and separation of these domains is
required for integrin signaling, it is still not clear how this signal is transmitted from the
transmembrane domain through two long extracellular legs to the ligand-binding headpiece. In
addition, integrin TM homomeric association was also observed. But the role of this interaction
remains elusive. In this work, the platelet integrin, IIb3, has been used to elucidate the roles of
integrin lower leg and TM homomeric association in integrin signalling.
We first addressed whether the separation of integrin αβ lower leg is critical for integrin
activation and outside-in signaling. Using a disulfide bond to restrict dissociation of the αsubunit Calf-2 domain and β-subunit I-EGF4 domain, we were able to abolish integrin inside-out
activation and outside-in signaling. In contrast, disrupting the interface by introducing a
glycosylation site into either subunit activated integrins for ligand binding through a global
conformational change. Our results suggest that the interface of the α-subunit Calf-2 domain and
β-subunit I-EGF4 domain is critical for integrin bidirectional signaling.
Formation of the TM homooligomers was observed in micelles and bacterial membranes
previously, and it has been proposed that this homomeric association is important for integrin
activation and clustering. We then addressed whether integrin TM domains form homooligomers
in mammalian cell membranes using cysteine mutagenesis scanning method. Our results show
that TM homomeric interaction does not occur before or after soluble ligand binding, or during
inside-out activation. In addition, even though the cysteine mutants and the heterodimeric
disulfide-bounded mutant could form clusters after adhering to immobilized ligand, the integrin
TM domains do not form homooligomers, suggesting that integrin TM homomeric association is
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not critical for integrin clustering or outside-in signaling. Therefore, the integrin TM
homooligomerization is not required for integrin activation, ligand binding and signaling.
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CHAPTER ONE:
GENERAL INTRODUCTION

1

Introduction
Integrins are a large family of cell adhesion receptors that mediate cell-cell, cellextracellular matrix (ECM), and cell-pathogen interactions. These receptors are principal
transmembrane proteins in that they connect the ECM with the actin cytoskeleton and a variety
of signalling molecules. As they integrate the extracellular and intracellular environments by
transmitting signals bidirectionally across the plasma membrane [1, 2], they were given the name
“integrin”. Cooperated with other proteins, integrins play critical roles in many biological
processes including hemostasis, inflammation, immune responses, development and cancer.
Integrins are usually in low affinity state under physiological conditions. When cells are
stimulated by external agents, specific intracellular molecules impinge on integrin cytoplasmic
domains, resulting in its conformational change and thus leading to increase of affinity for
extracellular ligands. This process is called inside-out signaling, which is the unique feature of
integrin receptors compared to other adhesion receptors. On the other hand, ligand binding
transduces signals from the extracellular environment to the cytoplasm and activates many
intracellular signaling pathways, a process known as outside-in signaling.
Integrins are expressed in all animals investigated and are of critical importance to them.
In vertebrates, 18 -subunits and 8 -subunits have been identified, forming at least 24 distinct
 pairs (Fig. 1.1). Each of the 24 integrins has a specific, nonredundant function [3]. In this
study, we investigated the bidirectional signalling of the most intensively studied integrin
IIb3.
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Figure 1.1 The mammalian integrin receptor family. 18  and 8  subunits form 24 heterodimers. 
subunits with gray hatching or stippling have inserted domain. The figure is adapted from the review
[3].

Biology of IIb3
IIb3, also known as glycoprotein IIb/IIIa, is expressed on the surface of platelets and
their precursor megakaryotes [4]. The formation of the IIb3 complex from both IIb and 3
subunits is necessary for the receptor to be expressed on the cell surface [5]. The assembly
occurs in the endoplasmic reticulum (ER), and then the complex is transported to the Golgi for
post-translational processing [6, 7]. Mature IIb contains 1008 amino acids and 3 has 762
amino acids [8 ]. As the main platelet integrin, IIb3 mediates platelet aggregation and thus is
essential for thrombosis and hemostasis. In unstimulated platelets, IIb3 is in the inactive, low
affinity state. The activation of the receptor occurs through inside-out signalling, in which the
platelets are stimulated by external agonists such as adenosine diphosphate (ADP), thrombin and
thromboxane A2, resulting in conformational change and thus facilitating the major ligand
fibrinogen binding. Platelets are therefore cross-linked through fibrinogen, causing platelet
3

aggregation. There are approximately 80,000 IIb3 copies on the membrane of each platelet
[9]. Dysfunction or shortage of IIb3 can result in the bleeding disorder Glanzmann
thrombasthenia [7]. The antagonists to IIb3 such as abciximab, eptifibatide and tirofiban were
prescribed for the prevention of thrombosis. But the therapy of Glanzmann thrombasthenia
remains unsatisfactory due to the fact that binding to platelets by these drugs can cause
conformational changes of IIb3, resulting in paradoxical thrombosis [7]. Investigation of the
structure and function of IIb3 will lead to additional and improved ways to prevent or treat the
pathological consequences of IIb3 dysfunction.

IIb3 Structure
Domain Organization and Overall Structure
Integrins are heterodimeric glycoproteins composed of two distinct noncovalently
associated  and  subunits, each with a large extracellular domain, a single spanning
transmembrane (TM) domain and a short cytoplasmic domain. Two groups of integrins have
been identified: one containing an extra von Willebrand factor type A domain (domain) in
their subunits; whereas the other including IIb3 lacking this domain (Fig. 1.1). As a typical
lacking integrin, IIb subunit extracellular portion consists of four domains: an N-terminal
seven-bladed –propeller domain and three –sandwich domains: the thigh, calf-1 and calf-2
domains. The 3 extracellular portion contains eight domains: an N-terminal domain, a
hybrid domain, a cysteine-rich PSI (Plexin-Semaphorin-Integrin) domain, four epidermal growth
factor-like (EGF-like) domains and a membrane proximal tail domain (TD) (Fig. 1.2). The –
propeller domain from the subunit and the I domain from the subunit assemble to form a
“headpiece”. Two “legs” are formed by the remaining extracellular domains of the two subunits
(Fig. 1.2b). Initially, IIb3 structure obtained by electron microscopy (EM) revealed a large
4

globular head domain of approximately 80 Å diameter followed by a long rigid stalk comprising
two flexible tails approximately 170 Å in length [10, 11]. Later on, X-ray crystal structures of the
extracellular domains of the integrin V3 and IIb3 revealed that the legs were severely bent
at the “genu” or knee (located between the Hybrid and Calf-1 domains in the , and between
EGF1 and EGF2 in the ), generating a V-shaped topology in which the head domain was
closely juxtaposed to the membrane-proximal portions of the stalks [12, 13] (Fig. 1.3, 1.5①).
Mutational and EM studies of different integrins established that the bent conformation
represents the physiological resting state [14, 15].

Figure 1.2 Integrin architecture. (a) Organization of domains within the primary structures. Some 
subunits contain an I domain inserted in the position denoted by the dotted lines. Cysteines and disulfides
are shown as lines below the stick figures. (b) Schematic of the course of the andsubunit polypeptide
chains through domains from the N to C termini. The figures are adapted from the review [16].

The -subunit Extracellular Domains
The N-terminal -propeller domain is formed by seven-fold ~60 amino acid repeats
arranged like blades of a propeller. Each repeat or blade contains a four-stranded  sheet. The
seven-bladed -propeller was initially predicted by computational methods [17] and later
confirmed by crystal structures [12, 13, 18, 19]. The -propeller forms the the  subunit head
domain and provides a critical interface with the -subunit (Fig. 1.3). On the bottom face of 5

propeller, four Ca2+ ions are chelated by loops in blades 4-7 [13]. Interestingly, the crystal
structure of IIb3 headpiece reveals a cap sub-domain that comprises four insertions in the propeller. Although probably not involved in allosteric regulation, the cap contributes
functionally to ligand binding as demonstrated by mutagenesis studies [20]. The marked
variation in the length and sequence of the inserts among  subunits suggests a role of the cap in
determining ligand binding specificity [19].

Figure 1.3 Crystal structure of integrin b3. (A) Structure of the b3 in the bent conformation.
(B) An extended model of b3 by torsion at the and  knees. (From PDB ID code 3FCS.)

The thigh, calf-1 and calf-2 domains, which constitute the remaining portion of the subunit extracellular domains, are three immunoglobulin-like-sandwich domains orderly
arranged after the -propeller domain and comprise the leg of the -subunit, with the thigh
domain in the upper leg and calf-1 and calf-2 domains in the lower leg (Fig.1.2b, 1.3). These
three domains have similar folds and are longer than typical Ig-like domains. A small Ca2+binding loop located between the thigh and calf-1 domains represents the -subunit genu (Fig.
1.3).
6

The -subunit Extracellular Domains
The -subunit organization is more complicated than that of the -subunit. The  I
domain is a highly conserved domain with ~240 residues and adopts a Rossmann fold, in which
-helices and -strands alternate in the secondary structure and a central -sheet is surrounded
by -helices in the tertiary structure. Additionally, the  I domain contains two additional
segments: one forms the interface with -propeller and the other is known as the specificitydetermining loop because of its role in ligand binding. The interacting interface between  I
domain and -propeller is much greater than any other domain-domain interface in integrins. In
addition, the  I domain contains three metal ion-binding sites: the metal ion dependent adhesion
site (MIDAS); SyMBS (synergistic metal ion binding site) and ADMIDAS (adjacent to
MIDAS), which shares some coordinating residues with the MIDAS. The  I domain MIDAS
appears to directly bind the ligand.
The  I domain is inserted in the-sandwich hybrid domain, which is in turn inserted in
the PSI domain (Fig. 1.2a). The hybrid domain makes extensive contact with the  I domain. Its
structure resembles the I-set Ig domains [21]. The PSI domain consists of a two-stranded
antiparallel  sheet flanked by two short helices [22]. The inserted topology of the  I domain
plays a critical role in its allosteric regulation and signaling, as discussed below.
PSI domain connects the hybrid domain with the lower leg of β-subunit, which contains
four I-EGF domains and a β-tail domain (Fig. 1.2b). The Vβ3 crystal structure revealed that IEGF3-4 domains assume the structure of a classic I-EGF fold and contain rich disulfide bonds
typical for EGF domains [12]. Recently, crystal structure of the entire extracellular domain of
IIbβ3 in a physiologically resting state has been solved [13] (Fig. 1.3). In this structure, there is
a highly acute bend between the I-EGF domains 1 and 2 (the β “knee”). In contrast, I-EGF
7

domains 2, 3 and 4 extend in an almost straight orientation. I-EGF4 domain is followed by β-tail
domain, which consists of a four-stranded β sheet and contacts with β I domain in the Vβ3
crystal structure but not in the IIbβ3 crystal structure [12, 13].
Transmembrane and Cytoplasmic Domains
In contrast to the crystal structures of integrin extracellular domains, the structural studies
of transmembrane and/or cytoplasmic domains produce conflicting results, in which the  and 
transmembrane and/or cytoplasimc fragments are either dissociated or associated with different
interfaces [23, 24-32]. Although early work failed to detect the association of the  and 
transmembrane and/or cytoplasimc domains [23, 24], later studies, which demonstrated the
interactions of the  and  subunits in this region [25-32], have been widely accepted. Despite
the fact that residues associate differently in various data, the GXXXG motif from the
transmembrane domains and GFFKR motif from the cytoplasmic domains were generally
considered to contribute to the association. Last year, a newly developed method combining
disulfide scanning with Rosetta computational modeling has been used to solve the structure of
IIbβ3 TM and cytoplasmic domains [30]. Since the structure is obtained based on experimental
data using intact integrins with the extracellular and cytoplasmic domains that regulate TM
association on the mammalian cell surface, we believe that it most likely represents the
physiological structure in the resting state. In this structure, the IIb GXXXG motif and their 3
counterparts of the TM domains associate with a ridge-in-groove packing (Fig. 1.4A). The IIb
TM -helix extends beyond the 23-residue TM hydrophobic segment and then Gly-991 of
GFFKR is a turn which changes the TM right-handed -helix to a left-handed one, making Phe992 and Phe-993 sit in the interface of IIb and β3 at the membrane/cytoplasm interface (Fig.
1.4B), and thus, this motif is critical for /β association. A salt bridge between IIb Arg-995 and
8

3 Asp-723 was proposed previously based on mutagenesis data [33]. In the structure, Arg-995
is close to both Asp-723 and Glu-726, consistent with this electrostatic interaction. However,
there are a variety of different conformations of the side chains of Arg-995 and Asp-723,
indicating that this salt bridge is not absolutely necessary for the association.

Figure 1.4 Structure of the integrin IIb3 transmembrane (TM) and cytoplasmic domains.
(A) The interface between two associating TM domains on the cell surface.
(B) Cytoplasmic fragment association of integrin IIb and 3 subunits in the Disulfide/Rosetta structure.
The figures are adapted from [30].

IIb3 Activation
The activation of IIb3 is tightly regulated through inside-out signalling. As described
above, upon stimulation of external agents, IIb3 undergoes conformational rearrangement and
facilitates ligand binding. Understanding the conformational changes of the overall structure and
individual domains of IIb3 is crucial to unravel the mechanism of its signalling transduction
and to successfully design a target drug. Two different models of IIb3 activation, the
switchblade model and the deadbolt model, have been proposed to interpret the overall
9

conformational rearrangement of integrins [15, 19, 34]. I will describe the first model in detail,
and discuss the second one later.
The Switchblade Model
The “switchblade” model proposes that the bent conformation represents the
physiological resting state, and upon activation integrins undergo a large global conformational
change that results in a fully extended conformation and a switchblade-like hybrid domain
swing-out [15, 19], leading to the conformational change at the ligand binding headpiece,
especially the  I domain, therefore increasing affinity for ligands (Fig. 1.5). This marked change
in tertiary structure is supported by X-ray crystallography [19], electron microscopy (EM) [14,
15, 35, 36], solution X-ray scattering [37], antibody epitope mapping [38], and mutational
studies [15, 16, 37, 39-44].

Figure 1.5 The switchblade model. Domain rearrangement of integrins during activation. The  subunit
lower legs are flexible and are therefore shown in what may be the predominant (solid representation) and
less predominant (dashed lines) orientations. The figures are adapted from the review [16].
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Conformational Change of  I Domain
The structure of the  I domain was first solved in the context of V3 extracellular
domains in the absence of ligand [12]. Subsequent mutagenesis studies [41-43, 45, 46] and the
structure of the IIb3 headpiece co-crystallized with different ligand mimetic drugs [19]
revealed conformational change in the open, high affinity state of the  I domain. With the
higher resolution (2.55Å) of IIb3 complete ectodomain crystal structure [13], more detailed
conformational changes in the  I domain can be obtained by superimposition of the headpieces
from this physiologically resting, unliganded, closed structure with the high-affinity, liganded,
open structure (Fig. 1.6). The inward movement of the 1-1 loop and the 1 helix is tightly
coupled with the downward displacement of the 6-7 loop and the 7 helix from the resting
state to the active state. This linkage is critical for propagation of conformational signals from
the ligand binding pocket to the other integrin domains and vice versa. The coordination of the
Met335 backbone carbonyl in the 6-7 loop to the ADMIDAS metal ion (Ca2+ in physiologic
condition) in the low-affinity conformation is broken in the high-affinity conformation. The
breaking of this coordination in turn enables the inward movements of 1-1 loop and the
ADMIDAS Ca2+ toward the MIDAS metal ion (Mg2+ in physiologic condition) (Fig. 1.6), which
is the major difference between the high and low-affinity conformations of the  I domain ligand
binding site, consistent with earlier findings [18, 19].
The Swing-out of the Hybrid Domains
Since the  I domain is inserted into the hybrid domain and they have extensive contact
to each other, the activation and movement of the  I domains will inevitably cause
conformational changes of the hybrid domain. As a consequence of the inserted topology of the
 I domain into the hybrid domain, the downward displacement of the 7-helix in the high11

affinity, liganded crystal structure results in complete remodeling of the interface between these
domains, leading to the swing-out of the hybrid domain [19] (Fig. 1.6). Compared to the closed
conformation, the hybrid domain swings out about 60°, resulting in the separation of the knees of
the  and  subunits by 70 Å (Fig. 1.6). The two conformations of the integrin headpiece were
supported by EM studies of integrin V3 [15] and 51 [35, 47] and a range of other studies
[40, 42, 47-49].

Figure 1.6 Conformational change and allosteric transmission by  I domains. Superposition of
closed and open structures of the  I domains and their linkages to hybrid and PSI domains. (From PDB
ID codes 3FCS and 2VDL). Nonmoving segments of backbone are shown as a gray worm. The moving
segments of the backbone and the MIDAS metal ions are cyan (closed) and red (open). The direction of
movement is indicated with arrows.
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Separation of the Lower Legs
Crystal [12, 13, 18] and EM [15] structures provide direct evidence that in the resting
state the membrane-proximal portion of the extracellular domains of the  and  subunits are in
close juxtaposition. Enforced association of the two stalks with acid/base coiled coils renders
integrin low affinity, whereas release of these constraints promotes high affinity ligand binding
[50]. Introducing a 10-residue flexible spacer between the extracellular domain and the TM
domain enhanced M2 ligand binding on the cell surface [51]. Crystal structure of the open
IIb3 headpiece [19] and EM structure of the entire V3 extracellular domains [15]
confirmed that the two stalks separate during integrin activation or ligand binding. The lower 
leg in the averaged EM images of the open conformation tended to disappear, suggesting that the
 lower leg is highly flexible and varied in conformations among individual particles [15].
Therefore, even though the crystal structure of the open IIb3 headpiece indicated that the
swing-out of the hybrid domain results in a 70 Å separation at the knees [19], the distance
between the two C-terminal stalks in the open conformations may vary, and this variation will
result in a spectrum of different conformations. The stalk separation is a key step for integrins to
transmit signals bidirectionally across the plasma membrane.
The Models of TM and Cytoplasmic Domain Activation
The TM and cytoplasmic domains are key for integrin inside-out and outside-in
signaling, since both signals must be conveyed across the plasma membrane. Several models
have been proposed to interpret how signals are transmitted across the cell membrane. These
models are distinguished by the positional changes of the TM domains in the lipid bilayer. In the
„piston‟ model, either the  subunit, the  subunit, or both subunits move vertically in the
membrane for integrin activation [52]. The „twist‟ and „scissor‟ models propose that a fulcrum,
13

formed by association of the  and  subunits within or nearby cell membrane, must occur for
signal transduction, based upon which the  and  TM domains are either „twisted‟ or
undergoing a scissor-like movement [52, 53]. Recently, the separation of TM and cytoplasmic
domains has become widely accepted, which is discussed as follows.
Many studies showed that deletions or mutations in the  and  subunit TM and
cytoplasmic domains, which are expected to destabilize / association, activate integrins [33,
54-57]. FRET study shows that in the resting state the integrin  and  subunit cytoplasmic
domains are close to one another, but undergo significant spatial separation upon inside-out
activation induced by phorbol ester or talin head domain or outside-in signaling induced by
ligand binding [58]. NMR studies of the integrin cytoplasmic tails suggest that their association
is weak, with significant differences observed between published structures [25-27], or that
association is undetectable [24]. These studies imply that the cytoplasmic interaction is modest
and/or transient. Binding of intracellular proteins such as RAPL [59] or the talin head domain
[60-62] to the integrin cytoplasmic tails induces tail separation and activate integrins for ligand
binding [25]. The structural basis for binding of talin head domain and filamin to the integrin 
cytoplasmic domain resulting in integrin activation has been demonstrated by NMR studies [6164]. The separation rather than rearrangement of TM domains was further supported by
mutagenesis studies, in which introduction of disulfide bridges to prevent or reverse separation
abolished the activating effect of cytoplasmic mutations [28], whereas mutations that disrupt the
TM interface activate integrins [29, 65, 66].
The tilting of the 3 helix within the membrane may provide another possible mechanism
for integrin activation. The comparisons of the Disulfide/Rosetta structure [30] with the NMR
structures of isolated IIb and 3 TM/cytoplasmic domain fragments [67, 68], which are
14

believed to represent the physiologically active state, gave some clues about the mechanism [69]
(Fig. 1.7). The isolated IIb and 3 TM/cytoplasmic NMR structures are similar with the
Disulfide/Rosetta structure. The dissociated 3 TM domain solved by NMR appeared to be a 30residue linear -helix extended into the cytoplasm, and instead of the 23 TM residues in the
Disulfide/Rosetta complex structure, 29 residues appeared to be embedded in the bicelle core. In
the NMR structure, 3 Lys-716 is followed by a 5-residue hydrophobic segment (L717LITI721),
and the continuous helix spanning the TM and juxtamembrane segments could undergo a
substantial tilt in the membrane, with snorkeling of the Lys-716 side chains into the polar
environment [67]. By contrast, the 3 helix embedded in lipid membrane in the
Disulfide/Rosetta complex structure is significantly shorter, suggesting that after dissociating
from the IIb helix, the 3 helix is tilted with an angle of 20-30° due to inserting of 5-6
additional hydrophobic residues to the hydrophobic lipid environment. The tilting of the 3 helix
can be caused by force transmission from the actin cytoskeleton since the integrins are activated
by force applied to the actin cytoskeleton that binds to the  cytoplasmic domain [13]. This
tilting of the 3 helix may be important for integrin activation and signaling.
Interestingly, the structure of integrin IIb3 TM and cytoplasmic domain complex was
also solved by NMR in the presence of phospholipid bicelles, and it was found to have a similar
interhelical interface to the Disulfide/Rosetta structure [31]. However, the NMR structure was
solved using an artificial hydrogen-bond constraint between the IIb(R995)- 3(D723). The
presence of the salt bridge was based on the fact that mutations of either residue affected the
helix-helix interaction as monitored by NMR. We propose that this electrostatic interaction is
important for the priming of helix-helix interaction. After forming more stable helix-helix
interaction, the salt bridge is probably not critical for further stabilization. Therefore, the NMR
15

structure might represent an “intermediate” or “transient” state between the physiological resting
state (represented as the Disulfide/Rosetta structure) and the dissociated active state (represented
as the NMR structure of the isolated monomers as discussed below) (Fig. 1.7). It is interesting
that the NMR structures of the complex have almost identical structures and angles within the
membrane to the isolated monomers, and there were substantial amounts of IIb and 3
monomers present in the solution used for determining the NMR complex structures. These
observations confirm our hypothesis that the NMR structure of the complex is an intermediate or
“transient” state.

Figure 1.7 Predicted model of integrin TM activation. (I) The resting state represented as
Disulfide/Rosetta structure; (II) the “intermediate” or “transient” state represented as NMR structure of
integrin IIb3 TM and cytoplasmic domain peptides (PDB ID 2K9J); (III) the activated state
represented as monomeric IIb and 3 NMR structures (PDB ID codes 2K1A and 2RMZ). The charges
shown in II and III are proposed to be important for the initial association of  and  subunits. The outer
bounds of the hydrophobic, interface, and polar region of the membrane are shown as black, red, and
green lines, respectively.
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Homooligomerization of TM Domains
Although the heterodimeric association of / TM domains in the resting state has been
widely accepted, the homomeric association of isolated integrin TM fragments was also
proposed [23, 70, 71, 72]. In 2001, Li et al. failed to detect the heterodimeric association between
TM  and  fragments in micelles using various methods including ultracentrifugation and NMR
study. Instead, they observed the  homodimers and  homotrimers [23]. Later, αIIb and β3 TM
helices were confirmed to form homooligomers in bacterial membranes using TOXCAT assay,
with the similar interfaces as in heterodimers [70, 72]. Asparagine mutagenesis in this region of
β3 subunit indicated that M701N and G708N can activate integrin for ligand binding.
Furthermore, G708N was believed to induce β TM homotrimers, integrin clustering and
phosphorylation of FAK [73]. Thus homooligomers were proposed to contribute to integrin
activation and clustering. Combined with the mutagenesis study of αIIb TM domain, a push-pull
model was proposed in which disruption of the / heterodimeric association of TM domains
pushes the integrin to the activated state, whereas homooligomerization pulls the equilibrium
toward activation [66]. Although integrin TM homooligomerization received support from
computer modeling [74], it has not been observed using intact integrins on mammalian cell
surface. Furthermore, the 3 G708N mutant was later found to increase ligand binding affinity as
a consequence of increased affinity rather than valency [29]. Therefore, it is necessary to further
test whether integrin TM domains form homooligomers during integrin activation and signaling.
The Deadbolt Model
As alternative or supplemental to the switchblade model, the “deadbolt” model posits that
the association between the  I domain from the headpiece and -TD domain from the lower leg
of  subunit is key to keep the integrin in the resting state, whereas dissociation of this interface
results in release of the constraint of  I domain involved in ligand binding and allows it to
undergo a subtle conformational change to shift the integrin to a high-affinity ligand binding
state. Thus the extension is not critical for initial integrin activation, but rather a post-ligand17

binding event in deadbolt model [34]. The model was also supported by many data [36, 75-78].
Additional structural analysis is necessary to evaluate these two models.

IIb3 Outside-in Signaling
Outside-in signaling of αIIbβ3 is triggered by extracellular ligand binding, which promotes
actin polymerization, cytoskeleton reorganization, and further cell spreading [7]. αIIbβ3 can bind
several Arg-Gly-Asp (RGD)-containing ligands including fibrinogen, von Willebrand factor
(vWF), vitronectin, fibronectin and thrombospondin. The ligand binding to αIIbβ3 involves
specific regions on the headpiece from both αIIb and β3 subunits [19]. It is believed that integrin
conformational rearrangements in outside-in signaling may occur in a similar way as in insideout signaling [15, 50, 58, 79]. In addition, the lateral association (clustering) of integrin
heterodimers, which occurs as a consequence of multivalent ligand binding [80, 81], was shown
to play a major role in outside-in signaling [82]. Although the exact mechanism for integrin
clustering remains unclear, it seems to regulate activation of several kinases including FAK, Src
and Syk [82-85]. Furthermore, the activated kinases phosphorylate the substrates leading to
intracellular signaling (Fig.1.8)

Figure 1.8 Working models of the integrin outside-in signaling. The  and  subunits are red and blue,
respectively, and the membrane is shown as a gray line (modified from [28]).
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An Overall Perspective
Numerous studies from different labs suggest that integrin bidirectional signaling across
the plasma membrane is accomplished by coupling extracellular conformational change to an
unclasping and separation of the  and  TM and cytoplasmic domains. Based on the above
description, we can summarize the basic conformational changes of integrins in their
bidirectional signaling. For inside-out signaling, when cells are stimulated by agonists such as
von Willebrand factor (VWF), thrombin and ADP, specific intracellular proteins, for example
talin, can interact with integrin  cytoplasmic domains through its FERM domain [86], further
initiating the separation of the cytoplasmic and TM domains. This event will destabilize the
extracellular / tail interface, concomitantly perturbing the tail/head interface and facilitating
the hybrid domain swing-out, which is coupled directly to the downward movement of the  I
domain 7 helix and thus the MIDAS rearrangement [15, 38]. There must exist an equilibrium of
different integrin conformational states in this process. The intracellular protein binding triggers
the change of the integrin bent conformation toward the more extended conformation. Integrin
conformational rearrangements may occur in a similar way for outside-in signaling [15, 50, 58,
79]. Ligand binding stabilizes integrin in the extended conformation with open headpiece and
two separate legs, resulting in the separation of the two cytoplasmic tails. Then, multivalent
ligand binding brings several integrins close to each other, leading to integrin clustering, and
kinases are recruited and activate each other, leading to intracellular signaling.
Work presented in this dissertation demonstrates that disruption of /association,
specifically, separation of two extracellular lower legs (IIb calf-2 domain and I-EGF4
domain) that induces a global conformational change of integrins is critical for transmitting the
bidirectional signals. Furthermore, the integrin TM homooligomerization was tested in order to
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understand TM signaling and clustering. In contrast to previous work [23, 70, 73], we did not
detect any homooligomers except for W967 mutant under various activating conditions. Our
results

therefore showed that disrupting

integrin heterodimeric

association of the

TM/cytoplasmic domains and the extracellular legs, but not the formation of homomeric
association, is critical for integrin activation and signaling.
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CHAPTER TWO:
DISSOCIATION OF THE -SUBUNIT CALF-2 DOMAIN
AND THE -SUBUNIT I-EGF4 DOMAIN IN INTEGRIN
ACTIVATION AND SIGNALING
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Introduction
Integrins are heterodimeric cell adhesion receptors that transmit signals bidirectionally
across the plasma membrane. Together with other proteins, they mediate cell-cell and cellextracellular matrix interactions and communication.

As functionally important signalling

molecules, they regulate a variety of cellular processes including growth, migration,
differentiation, and survival. Integrins are normally inactive on the surface of the cell. When
external agents stimulate cells, specific intracellular signals impinge on integrin cytoplasmic
domains resulting in changes in structure and ligand-binding affinity in the integrin extracellular
domain. In turn, binding of multimeric ligands triggers outside-in signalling, leading to several
cellular processes including cell spreading and kinase activation. Thus, integrin activation and
signalling are dependent on specific allosteric conformational changes in the integrin on the cell
surface.
Integrin α and β subunits each have a large extracellular domain, a single transmembrane
(TM) domain, and a short cytoplasmic domain (except the β4 subunit). The association of the 
and  subunit TM/cytoplasmic tails is critical for maintaining integrins in the low-affinity state,
whereas intracellular signals that destabilize  TM/cytoplasmic association result in integrin
activation [1-7]. Recently, structures of both the complex and the isolated monomers of the
TM/cytoplasmic domains were reported [8-11]. These structures show that in the resting state,
ridge-in-groove packing of the TM domain and the GFFKR motif in the  subunit cytoplasmic
domain are important for  association. Alternatively, integrins can be activated through the
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binding of intracellular molecules such as talin [12], which dissociates the  TM/cytoplasmic
domains and leads to a conformation with high affinity for ligands [2, 7, 13, 14].
However, the mechanism of how activation signals are transmitted from the TM domain
through two long extracellular legs to the ligand-binding headpiece remains elusive.

Two

different models have been developed in attempts to define this mechanism. The “deadbolt”
model has been proposed in which interaction at a small interface between the -tail domain
(βTD) CD loop (the deadbolt) and the  I domain 7 helix in Vβ3 ectodomain structure is
critical for stabilizing integrins in the low-affinity state [15]. The inside-out signal causes the
βTD CD loop to move away from the βI domain, enabling the 7 helix of the βI domain to
displace from the ligand-binding pocket. Thus, integrins assume high affinity for ligands even in
the bent conformation [16]. This model suggests that overall conformational change is not
critical for initial integrin activation, but rather a post-ligand-binding event. The model was
supported by transmission EM studies of the integrin V3 extracellular domain in complex
with a fibronectin fragment [17], and a number of other studies [18-21].

However, one study

that was designed to directly test this model found that deleting the CD loop residues, or
mutating these residues to Ala had no effect on integrin ligand binding [22].
By contrast, the other model, the “switchblade” model, has gained more experimental
support. This model proposed that upon inside-out activation, the integrin extracellular domains
rearrange through a “switchblade”-like movement to extend and assume high-affinity
conformations for ligands [23]. It suggests that this extension of extracellular integrin domains
is critical for integrin activation and signaling, since it preferentially places the ligand-binding
30

site away from the surface of the cell favoring ligand accessibility. At the same time, extension
enables hybrid domain swing-out, thus pulling the βI domain α7 helix through a crankshaft-like
displacement, converting the headpiece from the closed, low-affinity state to the open, highaffinity state [24].

This marked change in tertiary structure is supported by X-ray

crystallography [25], electron microscopy (EM) [14, 23, 26, 27], solution X-ray scattering [28],
antibody epitope mapping [29], and mutational studies [23, 28, 30-36]. However, the role of the
two extracellular legs on integrin signaling remains elusive. Although the separation of the upper
legs was observed by EM and crystal structures [23, 25], conformational change of the two lower
legs is less defined. Patients with mutations in calf-1 and calf-2 domains of αIIbβ3 showed
Glanzmann thrombasthenia [37], implying the significance of this region. Recently, a disulfide
bond introduced into α5β1 βTD and Calf-2 domain to restrict the leg separation blocked integrin
extension and signaling [38].
In this chapter, we tested the role of integrin lower leg separation on integrin activation
and signaling by introducing mutations that either prevent or disrupt the interface between the αsubunit Calf-2 domain and β-subunit I-EGF4 domain (Fig. 2.1). Our results showed that a
disulfide bridge that prevents separation of this interface completely abolished integrin inside-out
activation and outside-in signaling. In contrast, introduction of an N-glycan that disrupts this
interface resulted in high-affinity conformations. The results indicate that the separation of the
αβ legs is required for integrin activation and outside-in signaling.
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Figure 2.1 Mutations in the IIb3 structure. The Calf-2 domain is in pink, the I-EGF4 domain is in
green, and the TD domain is in cyan. A. The mutations are located one domain N-terminal to the βTD
CD loop (in salmon). The ligand-binding I domain is in marine and the α7-helix is in purple. Mutated
residues shown with spheres are residues R751 (magenta) and N753 (red) of IIb, and Y594 (orange) and
T603 (splitpea) of 3. B. The IIb_R751 (magenta) and 3_T603 (splitpea) are close to each other, and
mutating them to cysteines was expected to form disulfide-linked heterodimer. C. The IIb N753 (red)
and 3 Y594 (orange) are located at the interface, and introduction of a N-glycosylation site to these
positions was predicted to disrupt  association.
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Experimental Procedures
Cell Culture
HEK 293T cell line was purchased from American Type Culture Collection (ATCC,
Manassas, VA) and was maintained in Dulbecco‟s modified Eagle‟s medium (DMEM)
containing 10% fetal bovine serum (FBS) with 1X nonessential amino acids, 1X
penicillin/streptomyosin, 1X L-glutamine, 1X sodium pyruvate (100X stock solutions were
purchased from Invitrogen) at 37°C in 5% CO2 atmosphere. The total medium was changed
every other day.
Plasmid Construction, Expression, and Immunoprecipitation
Plasmids with sequences encoding full-length human αIIb and β3 were subcloned into
pEF/V5-HisA and pcDNA3.1/Myc-His (+), respectively [23]. The αIIb mutants F992A/F993A
(activating GAAKR mutant, denoted as α*), F755T, and α*R751C and the β3 mutants
Y594N/D596T and T603C were made using site-directed mutagenesis with the QuikChange kit
(Stratagene, La Jolla, CA). Constructs were transfected into HEK293T cells (American Type
Culture Collection, Manassas, VA) using a FuGENE transfection kit (Roche Applied Science,
Indianapolis, IN) according to the manufacturer's instructions. To detect the expression levels of
αIIb and β3 by flow cytometry staining, twenty-four or fourty-eight hours after transfection, cells
were detached and suspended in Tris-buffered saline (TBS) supplemented with 5mM Ca2+. Then
10 µg/ml of following monoclonal antibodies: AP3 (nonfunctional anti-β3 mAb, American Type
Culture Collection), 7E3 (anti-β3 mAb), and 10E5 (anti-αIIb mAb, kindly provided by B. S.
Coller, Rockefeller University, New York, NY) were incubated on ice for 30 min with the
suspended cells separately, followed by staining of FITC conjugated anti-mouse IgG on ice for
another 30 min. After wash, the samples were stored in phosphate-buffered saline (PBS) and
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were subjected to FACS scans using a FACScalibur flow cytometer (Becton Dickinson, San
Jose, CA, USA) from LSU School of Veterinary Medicine. To characterize disulfide-bond
formation and glycosylation, twenty-four hours after transfection, the HEK293T cells were
metabolically labeled with [35S] cysteine/methionine for 1.5 h before adding chase medium
containing 500 μg/ml of cysteine and 100 μg/ml of methionine, and cells were cultured for 17 h
and lysed in lysis buffer containing 20 mM Tris-buffered saline, pH 7.4 (TBS), supplemented
with 1 mM Ca2+, 1% Triton X-100, and 0.1% Nonidet P-40 [3]. The lysates were
immunoprecipitated with 1 µg of anti-β3 mAb AP3 and protein G-sepharose at 4°C for 1 h,
eluted with 0.5% SDS. After the addition of 1% Nonidet P-40, the protein was treated with or
without 500 units of PNGase F (New England BioLabs) at 37°C for 1h. Material was subjected
to 7.5% nonreducing SDS-PAGE and fluorography [3].
Two-Color Ligand Binding Assay on HEK293T Transfectants
Soluble binding of ligand mimetic IgM PAC-1 (BD Biosciences, San Jose, CA) and
Alexa Fluor 488-labeled human fibrinogen (Enzyme Research Laboratories, South Bend, IN)
was determined as previously described [31]. Briefly, transfected cells suspended in 20 mM
HEPES-buffered saline, pH 7.4 (HBS) supplemented with 5.5 mM glucose and 1% bovine serum
albumin were incubated on ice for 30 min with PAC-1 or Alexa Fluor 488-conjugated human
fibrinogen in the presence of either 5 mM EDTA, 5 mM Ca2+, 100 µM Ca2+/1 mM Mn2+ plus 10
µg/ml activating mAb PT25-2 (anti-αIIb, kindly provided by M. Handa, Keio University
Hospital, Tokyo, Japan) [39], or 1 mM Mn2+ plus 10 µg/ml activating mAb LIBS-1 (anti-β3,
kindly provided by M. H. Ginsberg, Scripps Research Institute, La Jolla, CA) [40]. For PAC-1
binding, cells were washed and stained with FITC-conjugated anti-mouse IgM on ice for another
30 min before being subjected to flow cytometry. Cells were also stained in parallel with Cy334

conjugated anti-β3 mAb AP3. Binding activity is presented as the percentage of the mean
fluorescence intensity (MFI) of PAC-1 or fibrinogen staining after background subtraction of the
staining in the presence of EDTA, relative to the MFI of the AP3 staining.
Ligand-Induced Binding Site (LIBS) Epitope Expression
LIBS epitope expression was measured as previously described [31]. Briefly, transfected
cells suspended in HBS supplemented with 5.5 mM glucose and 1% bovine serum albumin were
incubated with or without 50 µM GRGDSP peptide in the presence of 1 mM Mn2+ plus 10 µg/ml
anti-LIBS antibody. After incubation on ice for 30 min, cells were washed and stained with
FITC-labeled anti-mouse IgG on ice for 30 min. The stained cells were subjected to flow
cytometry, and LIBS epitope expression was expressed as the percentage of MFI of anti-LIBS
antibody relative to MFI of the conformation-independent anti-β3 mAb AP3.
Cell Adhesion Assays
Cell adhesion on immobilized human fibrinogen was assessed by the measurement of
cellular lactate dehydrogenase (LDH) activity as previously described [41].

Briefly, cells

suspended in HBS supplemented with 5.5 mM glucose and 1% bovine serum albumin and 1 mM
Ca2+ with or without 1mM DTT were added into flat bottom 12-well plates (1 × 105 cells/well)
precoated with 20 µg/ml fibrinogen and blocked with 1% bovine serum albumin.

After

incubation at 37°C for 1 h, wells were washed three times with HBS supplemented as indicated
above. Remaining adherent cells were lysed with 1% Triton X-100, and LDH activity was
assayed using the Cytotoxicity Detection Kit (Roche Applied Science) according to the
manufacturer's instructions. Cell adhesion was expressed as a percentage of bound cells relative
to total input cells.

35

Cell Spreading and Microscopy
Glass bottom 6-well plates (MatTek Corporation, Ashland, MA ) were coated with 20
µg/mL human fibrinogen in phosphate-buffered saline at pH 7.4 (PBS) overnight at 4°C, and
then blocked with 1% BSA at room temperature (RT) for 1 h. The transiently transfected
HEK293T cells were detached with trypsin/EDTA, washed three times with DMEM, and seeded
on fibrinogen-coated plates with or without 1mM DTT. After incubation at 37°C for 1 h, cells
were washed three times with PBS and fixed with 3.7% formaldehyde in PBS at RT for 10
minutes for microscopy.
Differential interference contrast (DIC) imaging was conducted on a Leica TCS SP2
spectral confocal system coupled to a DM IRE2 inverted microscope with a 63X oil objective.
For the quantification of cell spreading area, outlines of 100 randomly selected adherent cells
were generated, and the number of pixels contained within each of these regions was measured
using ImageJ software (Bethesda, Maryland).

Results
Mutations of IIb3 Extracellular Membrane-Proximal Stalk Stabilizes or Disrupts αβ Leg
Association
To test whether the conformational rearrangements of integrin lower legs are important,
we designed mutations at the interface between the αIIb-subunit Calf-2 domain and the β3subunit I-EGF4 domain (Fig. 2.1).

To mimic integrin inside-out activation, site-directed

mutagenesis was used to mutate two phenylalanine residues in the GFFKR motif of the αIIb
cytoplasmic domain to alanines (αIIb_F992A/F993A/β3, denoted α*/β). Cysteine residues were
introduced into the α*/β construct to test the effects of a disulfide-bridged mutant on integrin
inside-out signaling [3]. The distance between Cβ atoms of αIIb-subunit Arg751 and β3-subunit
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Thr603 in the αIIbβ3 crystal structure is 4.1 Å [42]. Therefore, cysteine residues introduced to
replace these two residues (α*_R751C/β3_T603C, denoted α*751C/β603C) were expected to
form a disulfide bond.
In addition to introducing this disulfide clasp to prevent the αβ dissociation, we also
designed mutations to disrupt this interface to determine whether disrupting the αβ leg
association affected ligand binding. N-glycosylation sites were introduced on the αIIb-subunit
Calf-2 domain and on the β3-subunit I-EGF4 domain. In the crystal structure, the IIb_N753
and 3_Y594 residues are at the interface between the Calf-2 and I-EGF4 domains (Fig. 2.1C)
and were predicted to be important for the  association. Therefore, introducing an N-glycan
chain to either residue was expected to disrupt the  association. The following mutants were
constructed to test this hypothesis: IIb_F755T/β3 (denoted F755T/β, resulting in Nglycosylation of N753 in αIIb) and αIIb/3_Y594N/D596T (denoted α/(Y594N/D596T),
resulting in N-glycosylation of Y594N in β3).
Expression of Wild Type and Mutant αIIbβ3 on HEK293T Cells
To determine the expression of wild type and mutant αIIbβ3, wild type and four mutated
αIIb and β3 subunits were co-transfected into HEK293T cells and subjected to immunostaining
flow cytometry (Fig. 2.2A). Two anti-β3 antibodies AP3 and 7E3, which recognize the β3 I and
hybrid domains, respectively, and one anti-IIb antibody 10E5, which recognizes the β-propeller
domain, were used to monitor cell surface expression. Wild-type and mutant integrins bound to
the three antibodies (Fig. 2.2A), suggesting that they adopted a native conformation on the cell
surface. To exclude the possible contribution of endogenous αV in HEK293T cell lines, β3
integrin alone was transfected into the cells, and none of these three antibodies bound (Fig.
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2.2A), suggesting that this cell line does not express endogenous αV integrin. Indeed, no αV
expression was detected by using the anti-αV antibody LM609 (data not shown).

Figure 2.2 Expression and immunoprecipitation of wild-type and mutant IIb3 integrins. A.
Immunofluorescent flow cytometry. HEK293T transfectants were labeled with AP3 (anti-3), 7E3 (anti3), and 10E5 (anti-IIb). Thick and thin lines show labeling of the IIb3 transfectant and the mock
transfectant, respectively. B. Immunoprecipitation. Lysates from 35S-labeled HEK293T cell
transfectants were immunoprecipitated with mAb AP3. Precipitates were subjected to nonreducing 7.5%
SDS-PAGE and fluorography.
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Nonreducing SDS-PAGE of

35

S-labeled, immunoprecipitated receptors showed that in

the activating mutant (Fig. 2.2B, lane 2), the α* and the β3 subunits migrated in a similar pattern
to the wild-type receptor (denoted α/β, Fig. 2.2B, lane 1). In comparison, the receptors with the
pair of cysteine mutants α*_R751C/β3_T603C formed a disulfide-linked receptor (Fig. 2.2B,
lane 3), and the efficiency of the disulfide-bond formation was close to 100%. The β3 subunit of
β3-glycosylated mutant α/(Y594N/D596T) (Fig. 2.2B, lane 4) migrated slightly slower than that
of the wild type (Fig. 2.2B, lane 1), whereas the αIIb subunit from this glycosylation mutant
migrated in a similar pattern to the wild type αIIb subunit, suggesting that there was an additional
glycan chain added only to the β3-subunit. For the αIIb-glycosylation mutant F755T/β (Fig.
2.2B, lane 5), the β3 subunit migrated in a similar pattern to the wild-type β3 (Fig. 2.2B, lane 1),
whereas the mutated αIIb subunit (Fig. 2.2B, lane 5) migrated slightly slower than its wild-type
counterpart (Fig. 2.2B, lane 1), consistent with the presence of an additional glycan chain.
Furthermore, these differences between the wild-type and glycosylation mutants disappeared on
deglycosylation by PNGase F (Fig. 2.2B, lanes 6-8), confirming the attachment of extra glycan
chains.
Separation of the α-subunit Calf-2 Domain and the β-subunit I-EGF4 Domain Is Required
for Integrin Inside-out Signaling
Integrin inside-out signals are transmitted from the cytoplasmic/TM domains to the
extracellular domains, leading to the conformational change of the ligand-binding headpiece,
resulting in high-affinity ligand binding. To study the role of the separation of the αIIb-subunit
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Calf-2 domain and the β3-subunit I-EGF4 domain in integrin activation, two-color flow
cytometry was used to determine the binding of the soluble ligand-mimetic antibody PAC-1 and
fibrinogen to the wild-type and mutant receptors on the HEK293 cell surface [4]. As shown in
Figure 3A, the expression level of receptors was monitored by the Cy3-labeled anti-β3 antibody
AP3. The Cy3-AP3 fluorescence intensity was divided into four domains that represented
specifically labeled receptors. The R1 and R2 domains contained cells designated as positive
expressers. Ligand binding affinity was monitored by the FITC-labeled PAC-1. Cells located in
the R2 and R4 domains are those with high-affinity ligand binding. In the presence of Ca2+, very
few cells with the wild-type αIIbβ3 (α/β) were located in the R2 domain, and most positive
expressers were in the R1 domain, indicating that wild-type αIIbβ3 bound very little ligandmimetic PAC-1antibody. This is consistent with a low-affinity conformation under these
physiological conditions.

In the presence of Mn2+ and activating antibodies PT25-2, most

positive expressers shifted to the R2 domain, indicating that wild-type αIIbβ3 bound PAC-1 with
high affinity (Fig. 2.3A). When the GFFKR motif of the αIIb was mutated to GAAKR, the
mutant receptor (α*/β) bound PAC-1 with high affinity even in the presence of Ca2+, since most
positive expressers were located in the R2 domain (Fig. 2.3A). The addition of the PT25-2
activating antibody did not change this pattern (Fig. 2.3A), suggesting that the GAAKR mutation
mimics integrin inside-out activation. When a disulfide bond was introduced to this activating
mutant (α*751C/ β603C), the ligand binding affinity in the presence of Ca2+ was reversed and a
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Figure 2.3 Ligand-binding activity of wild-type and mutant IIb3 integrins. A. Flow cytometry of
dot plots. B and C. Quantified soluble ligand-binding affinity. Cells were incubated with PAC-1 (A-B)
in the presence of 5 mM Ca2+ or 10 µg/ml PT25-2 plus 1 mM Ca2+, or FITC-fibrinogen (C) in the
presence of 5 mM Ca2+ or 10 µg/ml LIBS1 plus 100 µM Ca2+ and 1 mM Mn2+ as indicated. Binding
activities were determined by flow cytometry and expressed as described in Materials and Methods.
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majority of the positive expressers were located in the R1 domain (Fig. 2.3A), indicating that
preventing separation of the αβ legs by a disulfide bond abolishes the integrin inside-out
activation. In contrast, the two glycosylation mutants α/(Y594N/D596T) and F755T/β bound
PAC-1 with high affinity in the presence of Ca2+ alone, with most positive expressers located in
the R2 domain (Fig. 2.3A). The addition of the PT25-2 activating antibody did not influence
their ligand binding, suggesting that these two mutants constitutively bound ligand with maximal
affinity (Fig. 2.3A).
Figure 2.3B quantifies this data by measuring the MFI of FITC-labeled PAC-1. The
results confirmed that the wild-type receptor bound PAC-1 only in the presence of activating
conditions, whereas the GAAKR mutant bound PAC-1 constitutively even in the presence of
Ca2+ alone (Fig. 2.3B). The disulfide-bonded receptor reversed the GAAKR-induced inside-out
activation, but did not abolish the activating antibody-induced ligand binding. When N-glycan
chain was introduced into the αβ interface of either subunit, receptors bound PAC-1
constitutively (Fig. 2.3B). Soluble fibrinogen binding was also carried out and similar results
and conclusion were obtained (Fig. 2.3C). Taken together, these experiments suggest that
separation of the αβ lower legs is required and sufficient for integrin inside-out activation.
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Disruption of the Interface between the α-subunit Calf-2 Domain and the β-subunit I-EGF4
Domain Causes a Global Integrin Conformational Change
Priming and ligand binding induce IIbβ3 conformational changes that expose the LIBS
epitopes. LIBS epitopes are at the interfaces between the headpiece and tailpiece and between
the  and β legs so that they are buried in the bent conformation but exposed in the extended
conformation [23, 29]. To investigate the conformational state of the αIIbβ3 mutants, binding of
anti-3 LIBS mAb LIBS1 [43] was analyzed. The LIBS1 bound poorly to wild-type αIIbβ3 in
the presence of Ca2+ alone. The binding significantly increased when Mn2+ and the ligand
mimetic peptide GRGDSP were added (Fig. 2.4), suggesting that the ligand mimetic peptide
stabilizes integrins in the more extended conformation. The GAAKR mutant (α*/β) bound
LIBS1 better than the wild type in the presence of Ca2+ alone, suggesting that the mutation
mimicking inside-out signaling shifts the integrin towards a more extended conformation.
Addition of Mn2+ and GRGDSP peptide further increased binding of the GAAKR mutant to
LIBS1, indicating that this mutation cannot stabilize integrins in the fully extended and open
state. In comparison, introducing the disulfide-bond into this mutant (α*751C/β603C) slightly
decreased LIBS1 binding in the presence of Ca2+ (Fig. 2.4), suggesting that the disulfide-bridge
reverses the conformational change induced by inside-out activation. In contrast to the wild-type
and the GAAKR mutant receptors, the two glycosylation mutants (α/Y594N/D596T and
F755T/β ) bound LIBS1 in the presence of Ca2+ (Fig. 2.4), suggesting that separation of the two
legs stabilizes integrins in a more extended conformation. Thus, this conformational change
could explain their high-affinity ligand binding.
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Figure 2.4 Exposure of the LIBS1 eptitope. Cells were stained with anti-LIBS antibody LIBS1 in the
presence of 5 mM Ca2+ or 1 mM Mn2+ plus 50 µM RGD peptides (GRGDSP). LIBS epitope exposure
was determined as the percentage of MFI of anti-LIBS1 antibody relative to non-functional anti-3 mAb
AP3. Error bars are standard deviation (SD).

Separation of the α-subunit Calf-2 Domain and the β-subunit I-EGF4 Domain Is Crucial
for Cell-Adhesion and Spreading
We further determined how separation of the α-subunit Calf-2 domain and the β-subunit
I-EGF4 domain affects outside-in signaling by assaying cell adhesion and spreading. HEK293T
cells transiently transfected with wild-type and mutant αIIbβ3 were seeded on fibrinogenprecoated dish surfaces at 37°C for 1 h.

The amount of adherent cells was assessed by

quantifying the cellular lactate dehydrogenase (LDH) activity.

The results showed that in

contrast to previous studies in CHO transfectants [32, 41], all mutants with higher affinity for
soluble ligands adhered to immobilized fibrinogen similarly to the wild-type cells. This suggests
that the αIIbβ3 integrins in HEK293T cells are more active than similar integrins in CHO cells.
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In contrast, HEK293T cells transfected with a TM disulfide-bonded αIIbβ3 (α968C/β693C)
showed much less adhesion than those with a wild-type receptor (Fig. 2.5A). It is not surprising
that the disulfide bonded mutant (α*751C/β603C), which restricts separation of the αβ legs,
exhibited less adhesion compared to the activating mutant (α*/β) (Fig. 2.5A), since the adhesion
strength is dependent not only on the affinity of the receptors, but also on the spreading of the
cells on the immobilized ligands. As shown below, the disulfide-bonded mutants had defective
cell spreading, resulting in easier detachment of cells during washing. When these two disulfidebonded mutants were treated with DTT, the cell adhesion ability was recovered to the similar
level of the wild type with DTT.
To test if separation of the αβ lower leg can affect cell spreading, HEK293T transient
transfectants were coated on immobilized fibrinogen at 37°C for 1 h, followed by fixation and
microscopic analysis. Cells transfected with wild-type receptor demonstrated cell adhesion and
cell spreading (Fig. 2.5B). Previously, the TM disulfide-bonded αIIbβ3 (α968C/ β693C) in CHO
transfectants exhibited defective spreading, indicating that separation of the TM domains is
required for integrin outside-in signaling [41]. We confirmed that this disulfide-bonded mutant
in HEK293T cells exhibited similar defective spreading on fibrinogen (Fig. 2.5B), and even
though some cell could adhere to the immobilized fibrinogen, they remained round and did not
change size. The cell area was quantified, and showed that the disulfide-bonded mutant had a
significant decrease in adherent cell size comparing to that of the wild type (Fig. 2.5C). Thus,
this mutant was used as a negative control (Fig. 2.5B and C). As we discussed in our previous
paper [41], failure of outside-in signaling of the disulfide-bonded mutant was not likely due to
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the failure to bind ligands, since the mutant could bind ligands with similar level as the wild-type
(Fig. 2.3). The GAAKR mutant had little effect on cell spreading or on cell shape and size. By
comparison, the disulfide bonded mutant (α*751C/ β603C) had defective spreading (Fig. 2.5B
and C). Most adherent cells remained round and stayed the same size (Fig. 2.5B). To
demonstrate that the defect in spreading was due to the disulfide linkage, we treated the cells
with 1 mM DTT. Such treatment has shown to reduce the majority of engineered disulfides in
the mutant receptor and rescued cell spreading of the TM linkage (Fig. 2.5B and C) [41].
Similarly, the DTT treatment of the disulfide-bonded integrin α*751C/ β603C led to a rescue of
cell spreading (Fig. 2.5B and C). The effect of DTT treatment was unlikely due to the direct
effect on ligand binding affinity because DTT had little effect on wild-type cell adhesion and
spreading (Fig. 2.5). The quantitative adherent cell area of the disulfide bonded mutant cells
decreased by greater than 30% of that of the wild-type cells and of the GAAKR mutant cells.
This suggests that separation of the α/β lower leg is crucial for cell spreading. HEK293T cells
transfected with either glycosylation mutant could adhere to immobilized fibrinogen and
demonstrated substantial spreading (Fig. 2.5C). However, more glycosylation mutant cells than
wild-type cells remained round (Fig. 2.5B), suggesting that high-affinity mutants may have some
defective effect on outside-in signaling probably due to their effect on cell detachment. Further
research is required to determine the exact molecular mechanism of this defect.
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Figure 2.5 Cell adhesion and spreading. A. Adhesion of HEK293T transfectants in the presence of
1mM Ca2+ with or without DTT (1mM) to surfaces coated with 20 µg/ml fibrinogen. The amount of
bound cells was determined by measuring LDH activity as described in Materials and Methods. Data are
representative of three independent experiments, each in triplicate. B. DIC images of HEK293T
transfectants after adhering to immobilized fibrinogen at 37°C. a: /; b: / + DTT; c: α*/ β; d: α*751C/
β603C; e: α*751C/ β603C + DTT; f: α/(Y594N/ D596T); g: F755T/ β; h: α968C/ β893C; i: α968C/
β893C + DTT. The images are representatives of three independent experiments. Scale bar represents 10
µm. C. Quantification of the areas of adhering/spreading cells as described in Materials and Methods.
Error bars are SD. *** P <0.001.
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Discussion
When cells are activated, binding of intracellular molecules such as talin, dissociates the
 TM/cytoplasmic domains and leads to integrin activation. The current study demonstrates
that separation of the interface between the α-subunit Calf-2 domain and the β-subunit I-EGF4
domain is required for both integrin inside-out activation and outside-in signaling. It suggests
that the dissociation of the  TM/cytoplasmic domains is coupled with the dissociation of the
extracellular αβ lower legs, specifically, the interface between the α-subunit Calf-2 domain and
the β-subunit I-EGF4 domain. The mechanism by which this dissociation affects the
conformational change of the upper legs and ligand-binding headpiece leading to high-affinity
ligand binding remains to be determined.
When disulfide was introduced to the calf-2 and I-EGF4 interface, the mutant receptor
could be activated from outside by external reagents such as Mn2+ and activating antibodies. In
addition, LIBS epitope was exposed upon RGD binding, suggesting that the disulfide-bonded
mutant could adopt an extended conformation. Similar results were obtained when a disulfide
bond was introduced to the IIb3 TM domain [3, 41]. This is probably because of the highly
flexible 3 leg as suggested in the crystal structure [42]. Interestingly, when a disulfide bond was
introduced to the 51 calf-2 and TD interface, the mutant 51 failed to be extended. The
discrepancy may be due to the varied role of different interface on integrin activation, or due to
different integrin families. While the 3 integrins must response rapidly to environment [44],
changing their conformation within seconds from their default low affinity state to high affinity
state, the 1 integrins do not require a rigid control of their affinity [38].
It is still controversial whether integrin extension is required for integrin activation and
signaling. A cryoelectron tomography study showed that the IIb3 remains the same height
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after Mn2+ activation [20]. However, for particles the size of integrins, cryo-EM cannot
distinguish between a particle in two different orientations or two different conformations [45].
Since preparations of integrins, including αIIbβ3, often contain a mixture of particles with
different conformations [23, 42], the intermediate αIIbβ3 conformation may have resulted from
averaging particles together in extended and bent conformations [24]. In addition, it has been
shown that the activation of IIb3 by Mn2+ is limited [46], and the presence of Mn2+ might not
induce any global conformational changes, but may result in integrin aggregation, which would
complicate the samples for EM study. Recently, fluorescence lifetime imaging microscopy of
integrin αVβ3 on live cells indicated that integrins were in the bent conformation and no
extension occurred upon activation [21]. But similar to the cryo-EM image [46], this study may
just represent an average of all conformational states of integrins on the cell surface, and the
method might not be sensitive enough to monitor conformational change of a small portion of
integrin molecules. On the other hand, negative-staining EM studies of integrin αVβ3 [23],
αIIbβ3 [42], and αXβ2 [27, 47] showed that a substantial amount of integrin molecules were in
the extended conformation. Sklar and colleagues used FRET to measure the distance between an
FITC-labeled ligand-mimetic peptide bound to integrin 41 as the donor and a plasma
membrane dye as the acceptor [48], and showed that integrins extend about 50 Ǻ converting
between the resting and Mn2+-activated states. This distance is much less than the fully extended
conformational change, which will result in an approximately 200-Ǻ change. Therefore, the
study suggests that full extension is not necessary for integrin activation. Recently, Blue et al.
[49] introduced a disulfide bond between the IIb calf-1 and thigh domain to limit integrin
extension. They showed that this mutant had reduced ability to bind large ligands, suggesting
that integrin extension is important for ligand accessibility. Most interestingly, Ye et al. (2010)
utilized negatively-stained EM to study the conformational states of integrin αIIbβ3 embedded in
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phospholipid nanodiscs activated by the talin head domain. They showed that about 22% of
integrins in nanodiscs in the presence of the talin head domain were in the extended
conformation in the absence of other membrane proteins [14]. Binding of the talin head domain
is sufficient to shift the equilibrium towards extension, even though not all molecules are
stabilized in the fully extended state. Taken together, these studies suggest that when integrins
are activated by intracellular signals, equilibrium of different integrin conformers is shifted
toward a more extended state. However, the full extension of activated integrins may not be
necessary for ligand binding on the cell surface.
In the present study, the inside-out activation by GAAKR mutation only slightly exposed
the LIBS1 epitope (Fig. 2.4), and addition of a ligand-mimetic peptide further exposed the
epitope, suggesting that this inside-out activation does not induce full extension of all integrin
molecules. Inside-out activating signals may act by shifting the equilibrium, but not stabilizing
integrins in the fully extended state, which represents an extreme conformation. However, this
equilibrium shift is sufficient to initiate ligand binding. Regardless of the extent of integrin
extension, separation of the TM/cytoplasmic tails [3, 13, 14, 50] and dissociation of the lower αβ
legs as observed in the present and previous [38] studies are required for the transmission of the
inside-out signals to the ligand-binding headpiece. This observation is consistent with a previous
crystallography study of the complete ectodomain of integrin αIIbβ3 [42], which suggested that
breathing motions at the lower α and β legs might be a pathway for integrin extension, and this
motion shifts equilibrium towards a more extended and higher affinity states. EM studies of
three integrin families showed that the legs of the extended integrins are often crossed at the α
and β genu region [14, 23, 27, 42], suggesting that more structural assessments are needed to
determine how signals are conveyed between the headpiece and the lower legs.
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Outside-in signaling is induced by binding of integrins to multimeric ligands, which
results in integrin conformational change and clustering, both of which are critical for signaling.
A number of studies showed that binding of ligands or ligand-mimetic peptides stabilizes
integrins in the more extended conformation [23, 27, 42, 47]. However, it is not known whether
integrins assume a fully extended conformation on the cell surface upon ligand binding in the
physiological conditions. It is evident from the present study and previous publications that
dissociation of the lowerαβ legs and the TM/cytoplasmic tails is required for this signal
transduction.
In conclusion, our study strongly suggests that a global conformational change is required
to transmit integrin inside-out activation. Introduction of a glycan chain to dissociate the αβ
lower legs lead to both a high-affinity ligand binding state and a global conformational change,
whereas introduction of a disulfide bond to restrict the dissociation abolishes both inside-out and
outside-in signaling. Thus, this interface lies within the critical pathway of integrin bidirectional
signaling.
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CHAPTER THREE:
TEST OF THE INTEGRIN TRANSMEMBRANE DOMAIN
HOMOOLIGOMERIZATION DURING INTEGRIN
LIGAND BINDING AND SIGNALING
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Introduction
Integrins are cell adhesion molecules that are essential for many biological functions such
as cell migration, survival and differentiation. These functions are accomplished by integrin
bidirectional signalling across the cell membrane. Inside-out activation occurs when specific
intracellular molecules such as talin and kindlin bind to the integrin cytoplasmic domain, leading
to the integrin conformational change and therefore high affinity for extracellular ligands. Then,
binding of multimeric extracellular ligands results in outside-in signalling that is critical for
many cellular processes. It has been shown that integrin bidirectional signal transduction requires
integrin structural change and lateral distribution (clustering).
Integrins are type I transmembrane (TM) proteins consisting of two non-covalently
associated  and  subunits, each with a large extracellular domain, a single spanning TM
domain and a short cytoplasmic domain. Recent structural studies have greatly advanced our
understanding of how integrin assumes conformational change during inside-out activation [1-4].
Even though relatively short, the integrin TM/cytoplasmic domains play a crucial role in this
process. It has been shown that the association of  and  subunit TM/cytoplasmic domains is
critical for stabilizing integrins in the resting state [5-8]. When induced by binding of the 
subunit cytoplasmic domain through talin or other intracellular molecules, the TM/cytoplasmic
domains separate, driving integrin extension and shifting the ligand-binding / headpiece to an
open, high-affinity conformation [4, 9]. Recently, the structure of the TM/cytoplasmic domains
in the resting state was proposed based on Rosetta computational modeling and experimental
data using intact integrins on mammalian cell surface [8]. In this structure, the IIb GXXXG
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motif and their 3 counterparts of the transmembrane domains associate with ridge-in-groove
packing, and the IIb GFFKR motif and the 3 Lys-716 in the cytoplasmic segments play a
critical role in the / association. The structures of the complex and monomeric  and  subunit
TM/cytoplasmic domains have also been solved by NMR [10-12]. These studies have shed light
on structural basis of integrin TM/cytoplasmic domain signaling across the plasma membrane
[13].
In contrast to the role of the heterodimeric TM/cytoplasmic domain association and
dissociation, that of homooligomerization of integrin TM domains in integrin signaling remains
elusive. In 2001, NMR study in this region by Li et al. failed to detect the heterodimeric
association between the  and  subunit TM/cytoplasmic domains using TM/cytoplasmic
fragment peptides in micelles. Instead, they observed that the  and  fragments tend to form
homodimers and homotrimers, respectively [14]. Later, αIIb and β3 TM helices were confirmed
to form homooligomers in bacterial membranes using TOXCAT assay [15, 16]. The  and 
homomeric interactions have been widely studied by computational modeling [17-19]. These
studies showed that the homooligomerization interface and the heterodimerization motifs largely
overlap, but it seems that homomeric interaction is less specific than the heterodimeric
interaction [16]. In 2003, asparagine mutagenesis study in the TM region of β3 subunit (with
most experiments on the mutation 3_G708N) suggests that TM homooligomerization
contributes to integrin activation and clustering [20]. However, the mutation 3_G708N, which
was reported to enhance trimerization in detergent and increase ligand binding avidity in the
transfected CHO cells [20], was later found to activate the integrin by changing ligand binding
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affinity rather than valency [7]. Furthermore, mutations that disrupted homodimerization of
integrin TM domains, which also disrupted heterodimerization since two interfaces overlap, were
shown to activate integrins for ligand binding, suggesting that TM domain separation is
sufficient to activate integrins [21]. Therefore, it was proposed that integrin TM
homooligomerization is not a critical step for inside-out activation, but instead, it may help to
stabilize the integrin in the high affinity state [15].
It has been shown that integrin outside-in signaling requires both conformational change
and clustering of integrins. However, the mechanism of how integrins transmit these signals
across the plasma membrane through the TM/cytoplasmic domains remains unknown. More
specifically, it is unclear whether integrin TM homooligomerization plays any role in integrin
clustering and signaling, even though it has been proposed that it provides structural basis for
this process. Importantly, although  and  TM homooligomerization was found in micelles and
bacterial cell membrane [14, 16, 20-22], it has never been observed in mammalian cell
membrane using full-length integrins. In this paper, we tested whether integrin TM domains
form homooligomers in mammalian cell membrane using disulfide scanning of the intact integrin
IIb3. Our results showed that integrin TM domains do not form homooligomers before or
after soluble ligand binding or during integrin bidirectional signaling.

Experimental Procedures
Plasmid Construction and Transient Transfection
Plasmids coding for full-length human αIIb and β3 were subcloned into pEF/V5-HisA
and pcDNA3.1/Myc-His (+), respectively [23]. Amino acid substitution in TM and TM proximal
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regions to cysteine was made using site-directed mutagenesis with the QuikChange kit
(Stratagene). Constructs were transfected into 293T cells (American Type Culture Collection,
Manassas, VA) using a Fugene transfection kit (Roche Applied Science, Indianapolis, IN)
according to the manufacturer's instructions.
Immunoprecipitation
Twenty-four hours after transfection, 293T cells were treated with 20 μg/ml 2Bromopalmitate (2-BP), metabolically labeled with [35S] cysteine/methionine for 1.5 h before
adding chase medium containing 500 μg/ml of cysteine and 100 μg/ml of methionine, and cells
were cultured 17 h overnight [6]. Then cells were detached and suspended in Tris-buffered saline
(TBS) (106 cells in 100 μl) supplemented with 5 mM Ca2+, 1 mM Mn2+ with 3mg/ml fibrinogen
or 1 mM Mn2+ with 50 M RGD peptide and incubated at room temperature for 30 minutes.
Then, saponin was added to a final concentration of 0.02%, and 20 μM CuSO4/100 μM ophenanthroline was added by 10-fold dilution from stock solutions, and cells were incubated on
ice for 10 min. Oxidation was quenched by adding an equal volume of TBS containing Ca2+ and
5 mM N-ethyl maleimide. Cells were lysed by addition of an equal volume of 2% Triton X-100
and 0.1% NP-40 in the same buffer for 10 min on ice. Cell lysate was centrifuged and
immunoprecipitated with 1 g of anti-β3 mAb AP3 and protein G Sepharose at 4 °C for 2 h.
After three washes with lysis buffer, precipitated integrin was dissolved into 0.5% SDS sample
buffer and subjected to nonreducing 7.5% SDS-PAGE and fluorography [6].
For IIb W967C mutant, 2 mM DTT was added to the [35S]-labeled cells and incubated
at 37°C for 10 min, washed twice with TBS and then oxidized by Cu-phenanthroline on ice for
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10 min. Oxidation was quenched by adding an equal volume of TBS containing Ca2+ and 5 mM
N-ethyl maleimide. Cells were lysed and integrins were immunoprecipitated as described above.
To test whether integrins form homomeric disulfide bond after adhering to the
immobilized fibrinogen, [35S]-labeled cells were seeded on the surface of 6-well plates precoated with immobilized fibrinogen and incubated at 37°C for 1hr. After washing twice with
TBS, adherent cells were incubated on ice with Cu-phenanthroline and saponin and quenched
with 5 mM N-ethyl maleimide. Cells were lysed and integrins were immunoprecipitated as
described above.
Ligand-induced Binding Site (LIBS) Epitope Expression
LIBS epitope expression was measured as described [24]. Briefly, transfected cells
suspended in HBS supplemented with 5.5 mm glucose and 1% bovine serum albumin were
incubated either with 5 mM Ca2+, 3mg/ml fibrinogen or 50 μM Gly-Arg-Gly-Asp-Ser-Pro
peptide (GRGDSP) in the presence of 1 mM Mn2+ at 37°C for 15min, and then 10 μg/ml antiLIBS1 antibody was added. After incubation on ice for 30 min, cells were washed and stained
with FITC-labeled anti-mouse IgG on ice for 30 min. The stained cells were subjected to flow
cytometry, and LIBS epitope expression was expressed as the percentage of MFI of anti-LIBS
antibody relative to MFI of the conformation-independent anti-β3 mAb AP3.
Cell Spreading, Integrin Clustering and Microscopy
Glass bottom 6-well plates (MatTek Corporation, Ashland, MA) were coated overnight at
4°C with 20 µg/ml human fibrinogen in phosphate-buffered saline at pH 7.4 (PBS), followed by
blocking with 1% BSA at room temperature (RT) for 1 h. The transiently transfected HEK293T
cells were detached by trypsin/EDTA, washed three times with DMEM. Cells were seeded on
fibrinogen-coated dishes. After incubation at 37°C for 1 hour, cells were washed 3 times with
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PBS and fixed with 3.7% formaldehyde in PBS at RT for 10 minutes, or for integrin clustering,
10μg/ml anti-β3 mAb AP3 was added at room temperature for 30 minutes, followed by staining
with 10μg/ml FITC-conjugated goat anti-mouse IgG for 30 minutes at room temperature before
fixation. 400nM cytochalasin-D was added as control before seeding.
Differential interference contrast (DIC) imaging was conducted on a Leica TCS SP2
spectral confocal system, coupled to DM IRE2 inverted microscope with 63X oil objective. For
the quantification of cell spreading area, outlines of randomly selected 100 adherent cells were
generated and the number of pixels contained within each of these regions was measured using
ImageJ software (Bethesda, Maryland).
Cell Adhension
Cell adhesion on immobilized human fibrinogen was assessed by the measurement of
cellular lactate dehydrogenase (LDH) activity as described [25]. Briefly, cells suspended in HPS
supplemented with 5.5 mM glucose, 1% bovine serum albumin and 1 mm Ca2+ were added into
flat bottom 12-well plates (1 × 105 cells/well) that had been precoated with 20ug/ml fibrinogen
and blocked with 1% bovine serum albumin. After incubation at 37 °C for 1 h, wells were
washed three times with HBS supplemented as indicated above. Remaining adherent cells were
lysed with 1% Triton X-100, and lactate dehydrogenase activity was assayed using the
Cytotoxicity Detection Kit (LDH) (Roche Applied Science) according to the manufacturer's
instructions. Cell adhesion was expressed as a percentage of bound cells relative to total input
cells.

Results
Integrin TM Domains Do Not Form Homooligomers Before or After Soluble Ligand
Binding
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Previously, cysteine mutagenesis and heterodimeric disulfide scanning were used to
successfully identify the integrin IIb and 3 TM interface in mammalian cell membrane [6, 8].
Here we used the single cysteine mutations of the IIb and 3 TM region (IIb residues 965-995
and 3 residues 691-723, Fig. 3.1) and applied the similar method to determine if the IIb or 3
TM domain forms homooligomers during integrin signaling. As suggested by TOXCAT assay
[15, 16] and predicted by computer modeling [17-19], the IIb TM helix forms homodimers, and
the 3 TM helix forms homotrimers, with similar residues (for example GXXXG motif in the
IIb subunit) in their interface as observed in the heterodimeric interface. If this homomeric
interface is actually formed in the mammalian cell membrane, we expected that some single
cysteine mutations of these residues would form homodimeric disulfide bonds in the presence of
an oxidation catalyst such as Cu-phenanthroline. In addition, 2-BP was used to block cysteine
palmitoylation, which can inhibit disulfide formation; saponin was used to increase the
permeability of Cu-phenanthroline and the efficiency of disulfide bond formation as described
previously [8]. To confirm the efficiency of disulfide bond formation in the presence of Cuphenanthroline, several cysteine pairs (one from α and the other from β) at the TM or TM
proximal region, which have been shown to form heterodimeric disulfide bonds [6, 8], were used
as control.

Fig. 3.1 Sequences of the IIb and 3 TM regions. Segments predicted as TM are boxed. Residues
used for cysteine scanning in this study are indicated by heavy dots.
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As shown in Figure 3.2, the cysteine pair 971C/697C formed a heterodimeric disulfide
bond in the presence of Cu-phenanthroline, as described previously [6]. By contrast, none of the
single cysteine mutants of IIb TM regions formed homomeric disulfide bonds under these
conditions except for IIb W967C (Fig. 3.2). As reported previously [6, 7], IIb W967C, when
cotransfected with wild-type β3, formed a homomeric disulfide bond in the resting state, and
therefore, the IIbβ3 integrin associated to form a disulfide-bridged tetramer (IIbW967C/β3)2.
This residue is located outward, away from the heterodimeric interface or predicted homodimeric
interface [6, 7]. When DTT was added, the disulfide bond was reduced. After DTT was removed
and Cu-phenanthroline was added to catalyze disulfide formation, only trace amount of
homomeric disulfide was formed on the cell surface (Fig. 3.3A). We further traced the disulfidebond formation of IIb W967C mutant after

35

S labeling by lysing cells and

immunoprecipitating the protein at different time points (Fig. 3.3B). After 30 minutes of
labeling, IIb precursor was formed. Then after 1 hour, mature IIb subunit was formed and
trace amount of disulfide-bonded IIb was observed. In 1.5 hours, a significant amount of
disulfide-bonded IIb was formed. This suggests that the homomeric disulfide bond is formed
during biosynthesis and post-translational modification. Since this disulfide bond of the IIb
mutant is formed during biosynthesis and in the resting state in which heterodimeric TM
association is not affected, we excluded this mutant for the following studies. Except for this
cysteine mutant, none of the other 30 IIb cysteine mutants formed a homomeric disulfide bond
(Fig. 3.2), neither did any of the 34 β3 cysteine mutants (Fig. 3.4). These results suggest that the
IIb and β3 TM helices do not form homomeric association when IIbβ3 is in the resting state.
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Figure 3.2 Integrin IIb TM domains do not form homooligomers before and after soluble ligand
binding. Except for IIbW967C, none of the cysteine mutants of the IIb TM regions formed
homomeric disulfide bonds before or after soluble ligand binding.
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Figure 3.3 The homomeric disulfide bond of the IIbW967C was formed during biosynthesis. A.
Formation of the homomeric disulfide bond after DTT treatment. The 35S-labeled cells were treated with
or without 2 mM DTT at 37oC for 10 min. After washing with TBS, DTT treated cells were incubated
with or without Cu-Phenanthroline. B. Tracing the formation of disulfide bond of IIb W967C mutant
after labeling. The cells were lysed at different period of time after 35S-labeling and integrin IIb3 was
immunoprecipitated and subjected to 7.5% non-reducing SDS-PAGE.
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Figure 3.4 Integrin 3 TM domains do not form homooligomers before and after soluble ligand
binding. None of the cysteine mutants of the 3 TM regions formed homomeric disulfide bonds before
or after soluble ligand binding.
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To determine if the  and β TM domains form homooligomers after soluble ligand
binding, we used Mn2+ to activate integrin IIbβ3 followed by binding of soluble fibrinogen and
ligand-mimetic RGD peptide. It has been shown that ligand binding induces integrin
conformational changes that expose the LIBS (for Ligand-Induced Binding Site) epitopes, which
are located at the interfaces between the headpiece and tailpiece and between the  leg and β leg
so that they are buried in the bent conformation but exposed in the extended conformation [26,
27]. We used anti-3 LIBS mAb LIBS1 [28] to determine the conformational states of the
αIIbβ3 in the presence of Mn2+ with fibrinogen or RGD. The LIBS1 bound poorly to wild type
IIbβ3 in Ca2+ (Fig. 3.5), suggesting that it is in the bent conformation.

The binding

significantly increased when fibrinogen with Mn2+ or RGD with Mn2+ were added (Fig. 3.5),
suggesting that these ligands bound to integrins, and they stabilized integrins in the more
extended conformation. Disulfide scanning was used to test whether  and β TM domains form
homomeric interface after integrin bound to soluble fibrinogen and RGD peptide under the same
condition, and no homomeric disulfide formation was observe for any mutants except the
W967C as described above (Fig. 3.2, 3.3, 3.4), suggesting that after ligand binding, even
though integrins are stabilized in the more extended state and probably with two separating legs
and TM/cytoplasmic tails, homooligomerization does not occur for TM/cytoplasmic tails in
mammalian cell membrane.
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Fig. 3.5 Exposure of the LIBS1 eptitope. LIBS epitope exposure was determined as the percentage of
MFI of anti-LIBS1 antibody relative to non-functional anti-3 mAb AP3. Error bars are standard
deviation (SD).

Integrin TM Domains Do Not Form Homooligomers During Inside-out Signaling
Upon the stimulation of external agents such as thrombin and ADP, the intracellular
molecules (talin, kindlin etc.) can bind to the cytoplasmic domain of integrins, disrupting the
association of cytoplasmic domains and further triggering a cascade of inside-out signaling
events [29, 30]. Previously we have shown that dissociation of the TM heterodimers is critical
for integrin activation [6]. In addition to the TM heterodimeric association and dissociation, the
TM homomeric association was proposed to play an important role in this process [20, 21]. Here,
we designed experiments to test whether integrin TM region form homooligomers during insideout activation. It is well known that the GFFKR motif in the IIb cytoplasmic domain is crucial
for maintaining integrin in the resting state. When the two phenylalanines of the GFFKR motif
are mutated to alanines (GAAKR mutant), integrins are activated to bind ligands with high
affinity. Thus, this GAAKR mutant can be used to mimic integrin inside-out activation [6]. We
confirmed that the mutant bound fibrinogen constitutively; in addition, it bound LIBS1 much
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better than the wild type in Ca2+ condition (Fig. 3.5), indicating that the mutation shifts integrin
towards more extended conformation, well mimicking inside-out signaling. We made 6 single
cysteine mutants using this GAAKR construct, and co-transfected with the wild-type β3 integrin.
None of the IIb integrin cysteine mutants formed a homomeric disulfide bond (Fig. 3.6A).
Similar results were obtained when 34 β3 single cysteine mutants were co-transfected with the
IIb GAAKR mutant; none of these mutants formed a homomeric disulfide bond (Fig. 3.6B).
These results strongly suggest that during integrin inside-out activation across the mammalian
cell

membrane,

TM

homomeric

association

is

not

formed.

Therefore,

the

TM

homooligomerization does not play any role in this process.

Figure 3.6 Integrin TM domains do not form homooligomers during inside-out activation. A.
Cysteine mutations of the IIb GAAKR mutant were co-transfected with wild type 3 integrin. No
homomeric disulfide bond was formed for any of the IIb cysteine mutants. B. Cysteine mutations of the
3 TM region were co-transfected with the IIb GAAKR mutant. No homomeric disulfide bond was
formed for any of the 3 cysteine mutants.
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Integrin TM Domains Do Not Form Homooligomers After Adhering to Immobilized
Fibrinogen
After binding to immobilized ligands, integrins on the mammalian cell surface will
transmit outside-in signaling. We carried out a series of experiments to address whether TM
homomeric association is formed during this process. We randomly chose two αIIb and two β3
cysteine mutants and used them for cell adhesion and cell spreading assay. HEK293T cells
transiently transfected with wild-type and mutant αIIbβ3 were seeded on fibrinogen-precoated
dish surfaces at 37°C for 1 h. The amount of adherent cells was assessed by quantifying the
cellular lactate dehydrogenase (LDH) activity. All selected mutants could adhere to the
immobilized fibrinogen similarly to the wild-type receptor, whereas the disulfide bounded
mutant (α968C/β693C) showed much less adhesion, and DTT treatment which was used to
disrupt the disulfide bond was able to recover its adhesion to the similar level to the wild-type
with DTT (Fig. 3.7A). To test if the single cysteine mutations could affect cell spreading,
HEK293T transient transfectants were coated on the immobilized fibrinogen at 37°C for 1 h,
followed by fixation and microscopic analysis. Cells transfected with all single cysteine mutants
demonstrated cell spreading to the similar level to those transfected with the wild-type receptor.
By contrast, the disulfide bounded mutant (α968C/β693C) showed no spreading, and DTT
treatment restored cell spreading (Fig. 3.7B-C). These results confirmed that dissociation of the
TM heterodimers is required for integrin outside-in signaling as described previously using CHO
cell transfectants [25]. It also showed that the single cystein mutations in this region do not affect
the integrin adhesion to immobilized fibrinogen, nor do they affect outside-in signaling.
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Figure 3.7 Cell adhesion and spreading of randomly selected TM cysteine mutants. A. Adhesion of
HEK293T transfectants in the presence of 1mM Ca2+ to surfaces coated with 20 µg/ml fibrinogen. The
amount of bound cells was determined by measuring LDH activity as described in Materials and
Methods. Data are representative of three independent experiments, each in triplicate. B. DIC images of
HEK293T transfectants after adhering to immobilized fibrinogen at 37°C. The images are representatives
of three independent experiments. Scale bar represents 10 µm. C. Quantification of the areas of
adhering/spreading cells as described in Materials and Methods. Error bars are SD. *** P <0.001.
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It is widely believed that lateral association (i.e. “clustering”) of integrin heterodimers,
which occurs as a consequence of multivalent ligand binding [31, 32], plays a major role in
outside-in signaling (see review [33]). It was also shown that ligand binding can directly lead to
and stabilize separation of integrin cytoplasmic domains [34], and this integrin conformational
change is critical for outside-in signaling as well [25]. However, it remains unclear whether the
integrin TM homomeric interaction after the TM helix separation is critical for integrin
clustering. To assess formation of integrin clustering, HEK293T transfectants were allowed to
adhere to fibrinogen-coated substrates followed by fixation and staining with fluorescent antiIIb3 antibodies. Under these conditions, wild-type integrins and all cysteine mutants could be
readily detected in clustered patterns (Fig. 3.8). Interestingly, although disulfide bounded mutant
is defected with cell spreading, it formed the similar cell clustering as others, in contrast to the
negative control in which cytochalasin-D was used to disrupt the actin polymerization linked
integrin clustering (Figs. 3.7-3.8).
We then further determined, under the same condition, whether the integrin TM domains
formed homooligomers in the plasma membrane. HEK293T cells transfected with a variety of
IIb and β3 cysteine mutants were seeded on pre-coated fibrinogen surface at 37oC for 1 hr.
After cells fully adhered and spread on immobilized fibrinogen, Cu-phenanthroline was added to
catalyze disulfide bond formation. Four cysteine mutation pairs, 968C/693C, 971C/697C,
972C/697C and 955C/723C, were used as control to confirm the efficiency of oxidation.
Under this condition, four cysteine pairs formed disulfides efficiently. By contrast, none of the
IIb or 3 TM cysteine mutations formed a homomeric disulfide bond (Figs. 3.9). Since these
integrins adhered to the immobilized fibrinogen, clustered on the cell surface and transmitted
outside-in signaling leading to cell spreading, the results suggest that homomeric association of
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the integrin TM domains is not important for integrin functions. Similar results were obtained
when CHO cells were used (data not shown), suggesting that integrin TM/cytoplasmic domains
do not form homomeric interaction during integrin outside-in signaling in mammalian cells.

Figure 3.8 Integrin clustering of selected TM cysteine mutants. Confocal microscopy studies of
integrin clustering on the cell surface. Cells expressing IIb3 wild type and mutants were seeded on
fibrinogen-coated surface for 1h at 37°C in the presence or absence of cytochalasin-D (Cyto D). Attached
cells were then stained with anti-β3 mAb AP3 in the presence or absence of Cyto D for 30 minutes at
room temperature, followed by staining with FITC-conjugated goat anti-mouse IgG for 30 minutes at
room temperature. After fixation, cells were subjected to confocal microscopy.
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Figure 3.9 Integrin TM domains do not form homooligomers after cell adhering to the immobilized
fibrinogen. A. None of the IIb cysteine mutants formed homomeric disulfide bond after adhering to the
immobilized fibrinogen. B. None of the 3 cysteine mutants formed homomeric disulfide bond after
adhering to the immobilized fibrinogen.

75

Discussion
It has been shown that TM heterodimeric association stabilizes integrins in the resting
state; when integrins are activated by intracellular signals, two TM/cytoplasmic tails separate,
leading to conformational change of the ligand-binding extracellular regions, resulting in high
affinity for ligands [6-8, 12, 35, 36-39]. Therefore, equilibrium between the dissociated
monomers and associated heterodimers of the TM domains is critical for integrin inside-out
activation. Based on the observation that integrin TM helices formed homooligomers using
recombinant peptides in detergent [14, 20, 22], the GALLEX assay in bacteria [39], the
TOXCAT assay in bacteria [15, 16] and the computational modeling [17-19], TM homomeric
association has been suggested to be important for integrin activation [20-22]. Mutagenesis
studies on the proposed TM homomeric interface residues showed that these mutations could
lead to integrin activation, suggesting that heterodimer dissociation is sufficient to activate
integrins [21]. Therefore, a push-pull model was proposed in which after dissociation of the TM
heterodimer, integrins are stabilized by TM homomeric association [21].
Here our experiments on mammalian cell transfectants using full-length integrin IIb3
showed that the IIb and 3 TM domains do not form any homomeric association in the resting
state, nor do they form after soluble ligand binding. The only mutant that formed a homomeric
disulfide is IIb_W967C, as reported previously [6, 7]. We found that this homomeric disulfide
was formed during biosynthesis and in the integrin resting state, and dissociation of the TM
heterodimer is not required for its formation. Therefore, we do not think that the same
homomeric association occurs during integrin inside-out activation or outside-in signaling. We
found that except for this mutant, none of the other 30 IIb and 34 3 cysteine mutants formed a
homomeric disulfide bond before or after binding to soluble ligands. In addition, during integrin
inside-out activation, the integrin TM domains do not form any homomeric association that can
be detected by disulfide scanning. Integrins must be regulated to be activated and de-activated
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quickly in mammalian cells, even within seconds. It has been shown that detachment of integrin
from ligands in the trailing edge is critical for integrin functions [40], and mutations that
constitutively active integrins result in malfunctions [41-44]. Therefore, it is unlikely that
integrin TM domains form more stable homomeric association during inside-out signaling.
Although integrin clustering is known to participate in integrin signaling pathways [4548], the exact mechanisms of integrin clustering remain elusive. One mechanism proposes that
the integrin TM homooligomerization promotes integrin clustering [20]. Studies have established
that extracellular ligand binding triggers integrin conformational changes that promote oligomer
assembly through TM fragments [49-51]. In this study, we observed that after adhering to
immobilized fibrinogen integrins clustered on the cell surface, but we did not detect any integrin
TM homomeric interaction under this condition. Interestingly, the heterodimeric disulfidebonded integrin formed clusters, suggesting that even the dissociation of integrin / TM
domains is not required for integrin clustering. Therefore, our study suggests that integrin
clustering is induced by bringing several integrins physically close together by multimeric
ligands, and the TM homomeric association is not required for this process.
Even though the TM separation is not required for integrin clustering, it is critical for
integrin outside-in signaling [25]. We showed that all cysteine mutants could adhere and spread
on the fibrinogen-coated surface, suggesting that they could transmit signals into the cells after
binding to immobilized ligands. However, we did not observe any TM homomeric disulfide
formation in the same condition, indicating that the TM homomeric association does not occur
during integrin outside-in signaling. The reason why integrin outside-in signaling requires the
TM separation but not homomeric association is unknown. Based on the previous FRET studies
[34], we assume that ligand-induced TM separation is likely coupled to cytoplasmic domain
separation, implying that - cytoplasmic domain interactions somehow constrain or inhibit
kinase activation [7, 25, 29, 34, 52]. One possibility is that separation of TM and cytoplasmic
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domains induced by multimeric ligand binding is required for kinases or other intracellular
proteins to bind integrin cytoplasmic tails. On the other hand, some studies have shown that
certain tyrosine kinases, such as Src, associate constitutively with integrin IIb3 in platelets,
and platelet adhesion to fibrinogen causes a rapid increase in Src activation [53]. Thus, another
possibility is that the association of the integrin TM and cytoplasmic domains somehow
constrains the activity of integrin tail-bound kinases, whereas dissociation of the TM and
cytoplasmic domains releases these constraints. In either case, binding of multimeric ligands
brings integrins together, and at the same time, induces dissociation of the TM/cytoplasmic
domains, resulting in kinase auto-phosphorylation and activation. The current study strongly
suggests that during this process, the TM homomeric association does not play any role in kinase
activation.
In conclusion, our study shows that the integrin TM homomeric association does not
occur in mammalian cell membranes before or after soluble ligand binding, during inside-out
activation or outside-in signaling. Therefore, conformational change induced by intracellular
signals or extracellular ligands, more specifically, separation of TM and cytoplasmic domains,
but not the homomeric association is critical for integrin bidirectional signaling.
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CHAPTER FOUR:
SUMMARY AND GENERAL DISCUSSION
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Integrin signaling is often accompanied by its conformational rearrangement. Understanding
the biologically relevant conformational changes is important to unravel the mechanisms of
integrin signaling, and to further provide effective cues for drug design for integrin-involved
diseases. Although significant progress has been made in integrin structural studies and its
conformational changes in the past decade, many aspects, especially the conformational
alteration coupled with bidirectional signaling, need to be further investigated in more details.
To address the roles of integrin lower leg in integrin signaling, we have introduced a
disulfide bond and two glycosylation sites into the interface between the α-subunit Calf-2
domain and β-subunit I-EGF4 domain to either clasp or disrupt the association of this region.
Then we determined the effect of these mutants on ligand binding and outside-in signaling. In
addition, conformational states and cell adhesion were also tested (Chapter 2). Our results
showed that restricting the association by disulfide bond abolished the inside-out activation and
outside-in signaling, whereras disrupting the interface by glycosylation mutations activates the
integrins by a global conformational change. Therefore, separation of integrin lower leg is
required for inside-out activation and outside-in signaling.
In chapter 3, we used cysteine scanning mutagenesis method to test the possibility of
homomeric interaction under the context of the full length integrin in mammalian cells under
physiological and activating conditions. Our results showed that TM domains do not form
homooligomers in the mammalian cell membrane, which is in contrast with previous data
obtained in micelles and bacterial membranes in which the homooligomers were observed using
TM fragments. Further studies showed that disulfide-bonded integrin heterodimer is able to
aggregate to form clusters, even though its bidirectional signaling is blocked. It is generally
believed that integrin outside-in signaling is controlled by conformational change and clustering.
Our results show that integrin TM homomeric association does not play any role in integrin
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clustering. Furthermore, the integrin TM domains do not form homooligomers after adhering to
immobilized ligands. Taken together, the homooligomerization through TM helices is not
important for αIIbβ3 inside-out activation and outside-in signaling. We think that binding of
multimeric ligands brings integrins physically close to each other, leading to clustering; at the
same time, ligand binding triggers integrin leg separation, resulting in kinase activation.
For extracellular domains, two models have been proposed to address the possible
conformational changes upon inside-out activation: The “switchblade” model posits the full
extension is necessary for ligand binding, whereas in the “deadbolt” model, the extension is the
post-ligand binding event. Both models have received various supports. Studies have established
that integrins can exist in several states: low, intermediate, and high affinity states. The
coexistence of the two conflicting models may suggest that some intermediate conformations
could be enough to fulfill the mission of ligand binding at least in some signaling occasions.
Additional characterization of the biologically relevant conformational change is needed to fully
understand the story.
Currently, we are designing the experiments to examine these two models using FRET. A
FITC or Alexa Fluor®488 labeled antibody that binds to integrin headpiece and a dye that labels
the plasma membrane will be used as a donor-acceptor pair to determine the distance between
integrin headpiece and the plasma membrane using wild type and various mutant integrins under
physiological and activating conditions. Since this distance reflects the extent of integrin
extension, with different constructs under various conditions, we will be able to determine the
dynamics of conformational change in different scenarios. The FRET will also be used under the
conditions of inside-out activation, in which the talin head domain will be co-transfected with the
integrins, or the external activators such as ADP and thrombin will be added to induce the
platelet activation. No change of FRET signal upon addition of the activators would support the
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deadbolt model; while a loss of FRET signal would be consistent with the switchblade model; a
FRET signal change in between would lead us to propose a new model.
As far as the TM and cytoplasmic domains are concerned, although it is known that the
separation of TM is required for integrin signaling, the detailed mechanism needs to be further
investigated. Studies have shown that separation of the two associated subunits is caused by
either talin binding to two positions of integrin cytoplasmic fragments in succession or by talin
binding to cytoplasmic domain and inner membrane respectively. However, it was also proposed
that the lateral force caused by actin polymerization results in TM separation. Interestingly, it
was found that β TM fragment is tilted in the membrane bilayer in the active state. The tilting of
β TM domain may play an important role in the activation. More research is needed to define this
phenomenon. In addition, β cytoplasmic domains were considered as the scaffold for integrin
signaling, since a variety of intracellular proteins are directly or indirectly involved in connection
with this region. Much work remains to be done to uncover the intracellular signaling events.
In conclusion, our work presented in this dissertation has shed new light on the mechanism
of how integrins transmit signals bidirectionally across the plasma transmembrane. However,
many signaling events coupled with conformational rearrangement remain unclear. Future
investigation is necessary to advance our understanding of integrin signaling.
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